Global Malaria Vaccines Market is estimated to be valued at USD 620.0 Mn in 2025 and is expected to reach USD 1,432.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.7% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 620.0 Mn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
12.70%
2032 Value Projection:
USD 1,432.7 Mn
Figure. Malaria Vaccines Market Share (%), By Region 2025
Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected Anopheles mosquitoes. The currently available strategies for malaria prevention and control such as insecticide treated nets, spraying of insecticides and antimalarial drugs are proving insufficient to curb the spread of the disease. This makes malaria vaccines an urgent and vital public health tool to reduce malaria morbidity and mortality in endemic regions. Vaccines can provide long lasting immunity without requiring large healthcare infrastructure, thereby offering a cost-effective and sustainable solution towards malaria elimination goals.
Market Dynamics:
The global malaria vaccines market is primarily driven by the high disease burden of malaria worldwide, especially in African countries, massive funding for malaria vaccine development from global health organizations and growing acceptance of vaccines as an important public health intervention. However, technical challenges in developing an effective malaria vaccine owing to the complex life cycle of parasite Plasmodium and lack of comprehensive understanding of protective immune responses continue to restrain market potential. Meanwhile, ongoing advancements in vaccinology, immunology, and pathogen genomics have created opportunities for the development of novel vaccine design approaches and antigen targets. Further opportunities lie in expanding manufacturing capacity and ensuring successful uptake of malaria vaccines, once available, in malaria endemic populations through coordinated efforts of World Health Organization (WHO), Program for Appropriate Technology in Health, Malaria Vaccine Initiative (PATH MVI), and government immunization programs.
Key Features of the Study:
This report provides in-depth analysis of the global malaria vaccines market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global malaria vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Sumaya Biotech, GenVec, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Bharat Biotech, Serum Institute of India, Takeda Pharmaceutical Company, Novavax, Inc., Inovio Pharmaceuticals, Vaxart, Inc., and BioNTech SE
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global malaria vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global malaria vaccines market
Market Segmentation
Vaccine Type Insights (Revenue, USD Mn, 2020 - 2032)
Pre-Erythrocytic Vaccines
Erythrocytic Vaccines
Multi-Antigen Vaccines
Agent Insights (Revenue, USD Mn, 2020 - 2032)
Plasmodium Falciparum
Plasmodium Vivax
Anopheles Species
Age Insights (Revenue, USD Mn, 2020 - 2032)
Pediatric
Adult
Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
Public
Private
End Users Insights (Revenue, USD Mn, 2020 - 2032)
Hospitals
Specialty Clinics
Community Health Centers
Homecare
Regional Insights (Revenue, USD Mn, 2020 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
GlaxoSmithKline plc
Sanaria Inc.
Nobelpharma Co.
Sumaya Biotech
GenVec
Merck & Co., Inc.
Pfizer Inc.
Johnson & Johnson
Bharat Biotech
Serum Institute of India
Takeda Pharmaceutical Company
Novavax, Inc.
Inovio Pharmaceuticals
Vaxart, Inc.
BioNTech SE
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Malaria Vaccines Market, By Vaccine Type
Global Malaria Vaccines Market, By Agent
Global Malaria Vaccines Market, By Age
Global Malaria Vaccines Market, By Distribution Channel
Global Malaria Vaccines Market, By End Users
Global Malaria Vaccines Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends
4. Global Malaria Vaccines Market, By Vaccine Type, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Pre-Erythrocytic Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Erythrocytic Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Multi-Antigen Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Malaria Vaccines Market, By Agent, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Plasmodium Falciparum
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Plasmodium Vivax
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Anopheles Species
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Malaria Vaccines Market, By Age, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Pediatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Adult
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Malaria Vaccines Market, By Distribution Channel, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Public
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Private
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Malaria Vaccines Market, By End Users, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Community Health Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Homecare
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Malaria Vaccines Market, By Region, 2020 - 2032, Value (USD Mn)